Synopsis: Sakar Healthcare has secured its 3rd and 4th EU approvals for oncology injections, namely Carboplatin and Docetaxel, approved in Bulgaria and Bosnia. This made the stock jump by 5% approximately today The shares of this leading pharmaceutical company are in...
This pharma player announced a key milestone achieved by the company that will help increase its revenue and profitability. In this article, we will try to decode the information announced by the company. Price Movement With a market capitalization of Rs 683 crore,...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
